Hiromasa Yoshikawa
Internal medicineRetrospective cohort studyProspective cohort studyAdverse effectAngiogenesis inhibitorRheumatismOsteonecrosis of the jawBevacizumabAngiogenesisTargeted therapyOral ComplicationIn patientOral hygieneQuestionnaireMedicineImmune system
2Publications
0Citations
Publications 2
Newest
#1Nishizaki Hitomi (Kanagawa Dental College)
#2Morimoto Yoshinari (Kanagawa Dental College)
Last. Yutaka Imai (Dokkyo Medical University)H-Index: 1
view all 10 authors...
The aim of this study was to investigate the awareness and experience, among dental practitioners, of adverse events resulting from dental treatment of patients undergoing therapy with drugs that affect the immune system [angiogenesis inhibitors, biological agents, immunosuppressants, and disease-modifying anti-rheumatic drugs (DMARDs)]. For this purpose, a nationwide questionnaire survey was conducted. Questionnaires were sent to 2,050 dentists, of which 206 (10.1%) were completed and returned....
Source
#1Shin-ichi Yamada (Shinshu University)H-Index: 18
#2Hiroshi Kurita (Shinshu University)H-Index: 37
Last. Yutaka Imai (Dokkyo Medical University)H-Index: 1
view all 9 authors...
Abstract Background/purpose The prevalence of oral adverse events and dental treatments related complications during the molecular targeted drugs therapy remains unclear. The purpose of this study was to investigate the contents of dental treatment-related complications in Japanese patients during molecular targeted therapy. Materials and methods The nation-wide survey of dental treatment related complications was performed by the Japanese Society of Dentistry for Medically Compromised Patient a...
Source